tiprankstipranks
Luye Pharma Group Ltd. (DE:LUP)
FRANKFURT:LUP
Germany Market
LUP
Luye Pharma Group
RESEARCH TOOLSreports

Luye Pharma Group (LUP) Ratios

0 Followers

Luye Pharma Group Ratios

DE:LUP's free cash flow for Q4 2025 was ¥0.64. For the 2025 fiscal year, DE:LUP's free cash flow was decreased by ¥ and operating cash flow was ¥0.19. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.53 1.53 1.24 1.32 1.14
Quick Ratio
 1.44 1.44 1.15 1.21 1.06
Cash Ratio
 0.45 0.45 0.46 0.40 0.24
Solvency Ratio
 0.10 0.10 0.08 0.10 0.10
Operating Cash Flow Ratio
 0.04 0.18 0.02 0.20 0.17
Short-Term Operating Cash Flow Coverage
 0.05 0.27 0.02 0.31 0.24
Net Current Asset Value
¥ 1.05B¥ 1.05B¥ -550.42M¥ -1.26B¥ -2.42B
Leverage Ratios
Debt-to-Assets Ratio
 0.29 0.29 0.35 0.33 0.38
Debt-to-Equity Ratio
 0.59 0.59 0.73 0.67 0.89
Debt-to-Capital Ratio
 0.37 0.37 0.42 0.40 0.47
Long-Term Debt-to-Capital Ratio
 0.14 0.14 0.16 0.20 0.18
Financial Leverage Ratio
 2.04 2.04 2.09 2.03 2.38
Debt Service Coverage Ratio
 0.22 0.24 0.20 0.33 0.24
Interest Coverage Ratio
 1.83 1.81 2.04 1.36 1.87
Debt to Market Cap
 1.46 0.98 1.34 0.66 0.81
Interest Debt Per Share
 2.51 2.59 2.89 2.44 2.75
Net Debt to EBITDA
 2.61 2.44 3.00 2.50 3.74
Profitability Margins
Gross Profit Margin
65.99%65.99%66.72%68.44%69.22%
EBIT Margin
17.49%19.30%18.61%22.39%19.08%
EBITDA Margin
29.87%31.93%29.59%33.82%30.31%
Operating Profit Margin
19.70%19.70%18.93%14.94%14.72%
Pretax Profit Margin
14.97%14.97%13.85%11.40%11.20%
Net Profit Margin
9.81%9.81%7.79%8.67%10.11%
Continuous Operations Profit Margin
11.19%11.19%10.64%8.78%9.75%
Net Income Per EBT
65.50%65.50%56.23%76.08%90.30%
EBT Per EBIT
76.00%76.00%73.15%76.27%76.06%
Return on Assets (ROA)
1.88%1.88%1.59%2.09%2.49%
Return on Equity (ROE)
4.02%3.85%3.33%4.25%5.94%
Return on Capital Employed (ROCE)
5.43%5.43%6.09%5.29%5.97%
Return on Invested Capital (ROIC)
3.13%3.13%3.34%3.13%3.55%
Return on Tangible Assets
2.48%2.48%2.14%2.71%3.50%
Earnings Yield
8.19%6.45%6.16%4.23%5.38%
Efficiency Ratios
Receivables Turnover
 1.93 1.93 1.41 2.61 3.35
Payables Turnover
 1.86 1.86 2.93 2.53 3.29
Inventory Turnover
 2.24 2.24 2.21 2.34 2.38
Fixed Asset Turnover
 1.19 1.19 1.14 1.20 1.22
Asset Turnover
 0.19 0.19 0.20 0.24 0.25
Working Capital Turnover Ratio
 1.39 1.61 2.37 3.18 2.74
Cash Conversion Cycle
 155.16 155.16 299.25 151.34 151.07
Days of Sales Outstanding
 188.64 188.64 258.97 139.92 108.84
Days of Inventory Outstanding
 162.78 162.78 165.00 155.85 153.23
Days of Payables Outstanding
 196.25 196.25 124.72 144.42 111.01
Operating Cycle
 351.41 351.41 423.97 295.77 262.07
Cash Flow Ratios
Operating Cash Flow Per Share
 0.09 0.46 0.04 0.43 0.48
Free Cash Flow Per Share
 0.10 0.20 -0.41 0.12 0.14
CapEx Per Share
 0.02 0.26 0.45 0.31 0.33
Free Cash Flow to Operating Cash Flow
 1.18 0.44 -9.18 0.27 0.30
Dividend Paid and CapEx Coverage Ratio
 5.47 1.78 0.10 1.37 1.42
Capital Expenditure Coverage Ratio
 5.47 1.78 0.10 1.37 1.42
Operating Cash Flow Coverage Ratio
 0.04 0.19 0.02 0.19 0.18
Operating Cash Flow to Sales Ratio
 0.06 0.28 0.03 0.26 0.28
Free Cash Flow Yield
5.51%8.14%-20.10%3.41%4.36%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 10.46 15.50 16.25 23.66 18.60
Price-to-Sales (P/S) Ratio
 1.02 1.52 1.26 2.05 1.88
Price-to-Book (P/B) Ratio
 0.40 0.60 0.54 1.01 1.11
Price-to-Free Cash Flow (P/FCF) Ratio
 15.56 12.29 -4.98 29.29 22.95
Price-to-Operating Cash Flow Ratio
 18.57 5.38 45.70 7.90 6.80
Price-to-Earnings Growth (PEG) Ratio
 0.31 0.67 -2.27 -1.34 -0.03
Price-to-Fair Value
 0.40 0.60 0.54 1.01 1.11
Enterprise Value Multiple
 6.02 7.20 7.28 8.56 9.95
Enterprise Value
 12.41B 14.51B 13.05B 17.79B 18.03B
EV to EBITDA
 6.58 7.20 7.28 8.56 9.95
EV to Sales
 1.97 2.30 2.15 2.90 3.01
EV to Free Cash Flow
 30.10 18.59 -8.47 41.34 36.79
EV to Operating Cash Flow
 35.60 8.14 77.79 11.15 10.90
Tangible Book Value Per Share
 2.68 2.77 2.17 2.06 1.16
Shareholders’ Equity Per Share
 3.99 4.13 3.76 3.36 2.92
Tax and Other Ratios
Effective Tax Rate
 0.25 0.25 0.23 0.23 0.13
Revenue Per Share
 1.56 1.62 1.61 1.65 1.72
Net Income Per Share
 0.15 0.16 0.13 0.14 0.17
Tax Burden
 0.66 0.66 0.56 0.76 0.90
Interest Burden
 0.86 0.78 0.74 0.51 0.59
Research & Development to Revenue
 0.07 0.07 0.08 0.10 0.14
SG&A to Revenue
 0.40 0.40 0.40 0.10 0.10
Stock-Based Compensation to Revenue
 <0.01 <0.01 <0.01 <0.01 <0.01
Income Quality
 0.57 1.89 0.20 2.28 2.47
Currency in CNY